Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-08 4:50 pm |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
4,016 | $79.68 | $320,009 | 100,047 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-06 4:58 pm |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
7,995 | $54.04 | $432,031 | 317,618 (Direct) |
View |
| 2023-07-26 Sale |
2023-07-28 4:51 pm |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
5,030 | $47.95 | $241,199 | 639,378 (Direct) |
View |
| 2023-07-20 Sale |
2023-07-24 4:54 pm |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
300 | $46.81 | $14,044 | 646,973 (Direct) |
View |
| 2023-06-05 Sale |
2023-06-07 4:50 pm |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
10,235 | $44.86 | $459,142 | 330,943 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-06 Option Award |
2025-01-08 4:50 pm |
N/A 2035-01-06 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
56,250 | $0 | 100,047 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 4:55 pm |
N/A 2034-01-05 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
80,800 | $0 | 95,313 (Direct) |
View |
| 2023-10-04 Exercise |
2023-10-06 4:58 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
7,995 | $6.89 | 317,618 (Direct) |
View |
| 2023-10-04 Exercise |
2023-10-06 4:58 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
7,995 | $0 | 317,618 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-28 4:51 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
5,030 | $6.89 | 639,378 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-28 4:51 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
5,030 | $0 | 639,378 (Direct) |
View |
| 2023-07-20 Exercise |
2023-07-24 4:54 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
300 | $6.89 | 646,973 (Direct) |
View |
| 2023-07-20 Exercise |
2023-07-24 4:54 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
300 | $0 | 646,973 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-07 4:50 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
10,235 | $6.89 | 330,943 (Direct) |
View |
| 2023-06-05 Exercise |
2023-06-07 4:50 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
10,235 | $0 | 330,943 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-06 4:47 pm |
N/A 2033-01-06 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
144,200 | $0 | 144,200 (Direct) |
View |
| 2022-05-17 Exercise |
2022-05-19 4:36 pm |
N/A N/A |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
14,513 | $6.89 | 341,178 (Direct) |
View |
| 2022-05-17 Exercise |
2022-05-19 4:36 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
14,513 | $0 | 341,178 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 5:26 pm |
N/A 2032-01-04 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
107,000 | $0 | 107,000 (Direct) |
View |
Ownership |
2021-07-28 9:30 pm |
N/A 2031-04-29 |
Nuvalent Inc. | NUVL | Turner Christopher Durant Chief Medical Officer |
0 | $0 | 344,013 (Direct) |
View |